COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 74 filers reported holding COMPASS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $604,047 | +16.2% | 306,623 | +87.6% | 0.00% | – |
| Q2 2023 | $519,822 | +16149.5% | 163,466 | -83.3% | 0.00% | -100.0% |
| Q1 2023 | $3,199 | +676.5% | 978,403 | +1093.9% | 0.00% | – |
| Q4 2022 | $412 | -99.7% | 81,947 | +29.7% | 0.00% | – |
| Q3 2022 | $144,000 | +94.6% | 63,187 | +126.8% | 0.00% | – |
| Q2 2022 | $74,000 | +39.6% | 27,861 | -27.7% | 0.00% | – |
| Q1 2022 | $53,000 | +51.4% | 38,545 | +245.5% | 0.00% | – |
| Q4 2021 | $35,000 | – | 11,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |